1. Home
  2. ROIV vs MIDD Comparison

ROIV vs MIDD Comparison

Compare ROIV & MIDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$21.87

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Logo Middleby Corporation (The)

MIDD

Middleby Corporation (The)

HOLD

Current Price

$150.83

Market Cap

7.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
MIDD
Founded
2014
1888
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
7.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ROIV
MIDD
Price
$21.87
$150.83
Analyst Decision
Strong Buy
Buy
Analyst Count
8
8
Target Price
$24.31
$166.00
AVG Volume (30 Days)
8.2M
830.3K
Earning Date
02-09-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,329,000.00
$3,880,498,000.00
Revenue This Year
N/A
$1.93
Revenue Next Year
$741.42
$3.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.28
52 Week Low
$8.73
$110.82
52 Week High
$23.47
$182.73

Technical Indicators

Market Signals
Indicator
ROIV
MIDD
Relative Strength Index (RSI) 56.28 70.48
Support Level $21.36 $143.88
Resistance Level $22.72 $152.58
Average True Range (ATR) 0.72 3.21
MACD -0.13 -0.07
Stochastic Oscillator 32.69 80.92

Price Performance

Historical Comparison
ROIV
MIDD

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About MIDD Middleby Corporation (The)

The Middleby Corp is engaged in designing, manufacturing, marketing, distribution and service of a broad line of foodservice equipment used in all types of commercial restaurants and institutional kitchens, food preparation, cooking, baking, chilling and packaging equipment for food processing operations, and premium kitchen equipment including ranges, ovens, refrigerators, ventilation, dishwashers and outdoor cooking equipment used in the residential market. The company conducts its business through three principal business segments namely the Commercial Foodservice Equipment Group, the Food Processing Equipment Group and the Residential Kitchen Equipment Group. The firm derives majority revenue from Commercial Foodservice Equipment Group segment.

Share on Social Networks: